CLINICAL_TRIALS
trial_result
· 2021-05-05
Clinical Trial Update: BX-1 in Spasticity Due to Multiple Sclerosis [Phase 3]
Summary
Phase 3 clinical trial update for BX-1 in spasticity due to multiple sclerosis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bionorica SE | Conditions: Spasticity Due to Multiple Sclerosis | Phase 3 | Status: COMPLETED